TrialPloS one2019

Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial.

Janin Chandra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.